Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn MoreConnecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MOREEmpowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn moreWorking across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MOREDelivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreClinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn MoreHarness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MOREPharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MOREPrimary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORETrusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MOREOptimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MOREA single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MOREConnected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"Unlocking Pharmaceutical Potential: The Growing Role of Thai Clinics
Read moreImproving human health needs innovative thinkers. Unleash your potential with us.
Search JobsDiscover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MOREKUALA LUMPUR, MALAYSIA — May 19, 2025 — IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that IQVIA Malaysia has been honored with the prestigious CRO of the Year Award by Clinical Research Malaysia, presented by YAB Dato’ Seri Anwar Bin Ibrahim, Prime Minister of Malaysia, and YB Datuk Seri Haji Dr. Dzulkefly bin Ahmad, Minister of Health.
“We are proud of IQVIA’s longstanding work to help drive industry-sponsored clinical research in Malaysia,” says Benjamin Laverty, vice president of clinical operations in Southeast Asia, India, Australia and New Zealand. “Our mission is to accelerate innovation for a healthier world and this award celebrates the impact we are having on patients’ lives.”
This marks the eighth consecutive year IQVIA has been named CRO of the Year by Clinical Research Malaysia, demonstrating IQVIA’s deep expertise to deliver excellence in clinical research and its steadfast commitment to enhance patient outcomes globally.
Malaysia's R&D Landscape
The global clinical trials market size was valued at over USD $76 billion in 2024. It is projected to grow from USD 80.71 billion in 2025 to reach USD 132.05 billion by 2033, with a CAGR of 6.3%.
Malaysia has recorded 239 sponsored clinical research trials as of November 2024, contributing to over RM 330 million in Gross National Income in 2024, and close to RM 1.5 billion cumulatively since 2012. The country is on track to become a burgeoning hub for research and development in the region.
IQVIA Malaysia is equipped with a robust set of expertise, offering a full spectrum of clinical and commercial solutions for biopharmaceutical, medical device and other healthcare and life science companies.
For more information, please contact IQVIA.
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA:
Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com) +1.973.541.3558
Alissa Maupin, IQVIA Media Relations (alissa.maupin1@iqvia.com) +1.919.923.6785